Observations in APP Bitransgenic Mice Suggest that Diffuse and Compact Plaques Form via Independent Processes in Alzheimer's Disease

作者: Anna Lord , Ola Philipson , Therése Klingstedt , Gunilla Westermark , Per Hammarström

DOI: 10.1016/J.AJPATH.2011.01.052

关键词: TransgeneCell biologyIn vivoPathogenesisMutationDegenerative diseaseBiologyAlzheimer's diseaseFibrilExtracellularPathology

摘要: Studies of familial Alzheimer's disease suggest that misfolding and aggregation amyloid-β (Aβ) peptides initiate the pathogenesis. The Arctic mutation Aβ precursor protein (APP) results in AD, is more prone to form protofibrils extracellular deposits. Herein demonstrated burden diffuse deposits but not compact plaques increased when tg-Swe mice are crossed with tg-ArcSwe synthesizing low levels Aβ. bitransgenic mice, which contain primarily wild-type Aβ42, accumulate regions both without transgene expression. However, APP processing, compared tg-Swe, remains unchanged young whereas Aβ42 accelerated fibril architecture altered vitro vivo a level introduced. Thus, number likely due physical interactions between Aβ42. selective increase single type parenchymal deposit suggests different pathways lead formation plaques. These findings could have general implications for pathogenesis particular relevance patients heterozygous mutation. Moreover, it further illustrates how neuropathologic features can be manipulated by mechanisms similar those originally conceptualized prion research.

参考文章(60)
Anna Lord, Hillevi Englund, Linda Söderberg, Stina Tucker, Fredrik Clausen, Lars Hillered, Marcia Gordon, Dave Morgan, Lars Lannfelt, Frida E. Pettersson, Lars N. G. Nilsson, Amyloid-β protofibril levels correlate with spatial learning in Arctic Alzheimer’s disease transgenic mice FEBS Journal. ,vol. 276, pp. 995- 1006 ,(2009) , 10.1111/J.1742-4658.2008.06836.X
Charlotte Sahlin, Anna Lord, Kristina Magnusson, Hillevi Englund, Claudia G. Almeida, Paul Greengard, Fred Nyberg, Gunnar K. Gouras, Lars Lannfelt, Lars N.G. Nilsson, The Arctic Alzheimer mutation favors intracellular amyloid-beta production by making amyloid precursor protein less available to alpha-secretase. Journal of Neurochemistry. ,vol. 101, pp. 854- 862 ,(2007) , 10.1111/J.1471-4159.2006.04443.X
Lennart Mucke, Eliezer Masliah, Gui-Qiu Yu, Margaret Mallory, Edward M. Rockenstein, Gwen Tatsuno, Kang Hu, Dora Kholodenko, Kelly Johnson-Wood, Lisa McConlogue, High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. The Journal of Neuroscience. ,vol. 20, pp. 4050- 4058 ,(2000) , 10.1523/JNEUROSCI.20-11-04050.2000
Harry LeVine, QUANTIFICATION OF BETA -SHEET AMYLOID FIBRIL STRUCTURES WITH THIOFLAVIN T Methods in Enzymology. ,vol. 309, pp. 274- 284 ,(1999) , 10.1016/S0076-6879(99)09020-5
H Mori, K Takio, M Ogawara, D.J. Selkoe, Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. Journal of Biological Chemistry. ,vol. 267, pp. 17082- 17086 ,(1992) , 10.1016/S0021-9258(18)41896-0
K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, L. McConlogue, Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 1550- 1555 ,(1997) , 10.1073/PNAS.94.4.1550
Jin G Sheng, Donald L Price, Vassilis E Koliatsos, None, Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis The Journal of Neuroscience. ,vol. 22, pp. 9794- 9799 ,(2002) , 10.1523/JNEUROSCI.22-22-09794.2002
Orly Lazarov, Michael Lee, Daniel A. Peterson, Sangram S. Sisodia, Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice The Journal of Neuroscience. ,vol. 22, pp. 9785- 9793 ,(2002) , 10.1523/JNEUROSCI.22-22-09785.2002
Thomas Wisniewski, Blas Frangione, Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neuroscience Letters. ,vol. 135, pp. 235- 238 ,(1992) , 10.1016/0304-3940(92)90444-C